Cargando…
Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with metastatic Merkel cell carcinoma
OBJECTIVES: For valid and reliable assessment of patients’ Health-Related Quality of Life (HRQoL), it is crucial to use psychometrically robust instruments. In the context of rare diseases such as Merkel cell carcinoma (MCC), validated disease-specific instruments are often not available. The Functi...
Autores principales: | Bharmal, Murtuza, Nolte, Sandra, Henry-Szatkowski, Mickaël, Hennessy, Meliessa, Schlichting, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236271/ https://www.ncbi.nlm.nih.gov/pubmed/32430019 http://dx.doi.org/10.1186/s12955-020-01402-3 |
Ejemplares similares
-
Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma
por: Bharmal, Murtuza, et al.
Publicado: (2017) -
Correction to: Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma
por: Bharmal, Murtuza, et al.
Publicado: (2019) -
Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab
por: Bharmal, Murtuza, et al.
Publicado: (2020) -
How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical trial
por: Bharmal, Murtuza, et al.
Publicado: (2018) -
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma
por: D’Angelo, Sandra P., et al.
Publicado: (2019)